BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25338522)

  • 1. Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples.
    Tario JD; Chen GL; Hahn TE; Pan D; Furlage RL; Zhang Y; Brix L; Halgreen C; Jacobsen K; McCarthy PL; Wallace PK
    Cytometry B Clin Cytom; 2015 Jan; 88(1):6-20. PubMed ID: 25338522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.
    Maguire O; Chen GL; Hahn TE; Brix L; McCarthy PL; Wallace PK; Minderman H
    Methods; 2017 Jan; 112():75-83. PubMed ID: 27327144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis.
    Hobeika AC; Morse MA; Osada T; Ghanayem M; Niedzwiecki D; Barrier R; Lyerly HK; Clay TM
    J Immunother; 2005; 28(1):63-72. PubMed ID: 15614046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
    Yao J; Bechter C; Wiesneth M; Härter G; Götz M; Germeroth L; Guillaume P; Hasan F; von Harsdorf S; Mertens T; Michel D; Döhner H; Bunjes D; Schmitt M; Schmitt A
    Clin Infect Dis; 2008 May; 46(10):e96-105. PubMed ID: 18419478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life.
    Attaf M; Roider J; Malik A; Rius Rafael C; Dolton G; Predergast AJ; Leslie A; Ndung'u T; Kløverpris HN; Sewell AK; Goulder PJ
    Front Immunol; 2020; 11():1587. PubMed ID: 33101265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells.
    Gatault P; Al-Hajj S; Noble J; Chevallier E; Piollet M; Forconi C; Gaudy-Graffin C; Thibault G; Miquelestorena-Standley E; Halimi JM; Büchler M; Lemoine R; Baron C
    Am J Transplant; 2018 Aug; 18(8):1904-1913. PubMed ID: 29377506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
    Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
    J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.
    Banas B; Böger CA; Lückhoff G; Krüger B; Barabas S; Batzilla J; Schemmerer M; Köstler J; Bendfeldt H; Rascle A; Wagner R; Deml L; Leicht J; Krämer BK
    BMC Immunol; 2017 Mar; 18(1):15. PubMed ID: 28270092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.
    Maecker HT; Moon J; Bhatia S; Ghanekar SA; Maino VC; Payne JK; Kuus-Reichel K; Chang JC; Summers A; Clay TM; Morse MA; Lyerly HK; DeLaRosa C; Ankerst DP; Disis ML
    BMC Immunol; 2005 Jul; 6():17. PubMed ID: 16026627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
    Abu-Khader A; Krause S
    Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation.
    Heijnen IA; Barnett D; Arroz MJ; Barry SM; Bonneville M; Brando B; D'hautcourt JL; Kern F; Tötterman TH; Marijt EW; Bossy D; Preijers FW; Rothe G; Gratama JW;
    Cytometry B Clin Cytom; 2004 Nov; 62(1):1-13. PubMed ID: 15468327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.
    Abate D; Saldan A; Forner G; Tinto D; Bianchin A; Palù G
    J Virol Methods; 2014 Feb; 196():157-62. PubMed ID: 24216234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.
    Dolton G; Lissina A; Skowera A; Ladell K; Tungatt K; Jones E; Kronenberg-Versteeg D; Akpovwa H; Pentier JM; Holland CJ; Godkin AJ; Cole DK; Neller MA; Miles JJ; Price DA; Peakman M; Sewell AK
    Clin Exp Immunol; 2014 Jul; 177(1):47-63. PubMed ID: 24673376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8
    Ciáurriz M; Beloki L; Bandrés E; Mansilla C; Zabalza A; Pérez-Valderrama E; Lachén M; Ibáñez B; Olavarría E; Ramírez N
    Cytometry B Clin Cytom; 2017 Mar; 92(2):153-160. PubMed ID: 26918565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversified phenotype of antigen specific CD8+ T cells responding to the immunodominant epitopes of IE and pp65 antigens of human cytomegalovirus.
    Xu J; Wu R; Xiang F; Kong Q; Hong J; Kang X
    Cell Immunol; 2015 Jun; 295(2):105-11. PubMed ID: 25880101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of human cytomegalovirus-antigen in peripheral blood cells by using flow-cytometer].
    Honda J; Okubo Y; Arikawa K; Kumagai M; Kuwamoto M; Oizumi K
    Kansenshogaku Zasshi; 1996 Sep; 70(9):923-30. PubMed ID: 8921675
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.